Matinas Biopharma

Get Full Access

Description

  • Matinas BioPharma (NYSE MKT: MTNB) is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. The Company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead drug candidate MAT2203, currently in Phase 2, is an orally-administered, encochleated formulation of amphotericin B (a broad spectrum fungicidal agent). The Company has an open Investigational New Drug (IND) application for MAT2501, currently in Phase 1, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) for acute bacterial infections, including non-tuberculous mycobacterium (NTM) and multi-drug resistant gram negative bacterial infections.The Company's lead anti-infective product candidates, MAT2203 and MAT2501, position Matinas BioPharma to become a leader in the safe and effective delivery of anti-infective therapies utilizing its proprietary lipid-crystal nano-particle cochleate formulation technology.
  • location

    Headquarters:1545 Route 206 Suite 302, Bedminster, New Jersey, United States

    More
  • Matinas Biopharma phone

    Phone Number: +1 908-443-1860

  • Matinas Biopharma website

    Website: https://www.matinasbiopharma.com

  • Matinas Biopharma employees

    Employees:25

  • Matinas Biopharma revenue

    Revenue:$10 - 50M

  • Matinas Biopharma legal name

    Legal Name:Matinas Biopharma

  • Matinas Biopharma's Social Media

    Matinas Biopharma linkedin Matinas Biopharma facebook Matinas Biopharma twitter
  • done Is this data correct?
  • |  NAICS Code: 541715  |

    Show More
Person level website identification

CEO for Matinas Biopharma

Jerry Jabbour

Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Terry Ferguson

Chief Medical Officer

Hui Liu

Chief Technology Officer

Theresa Matkovits

Chief Development Officer

Keith Kucinski

Chief Financial Officer

Thomas Hoover

Chief Business Officer

Frequently Asked Questions regarding Matinas Biopharma

  • Where are Matinas Biopharma's Headquarters?

    Matinas Biopharma's Headquarters are in 1545 Route 206 Suite 302,Bedminster,New Jersey,United States

  • What is Matinas Biopharma's phone number?

    Matinas Biopharma's phone number is +1 908-443-1860

  • What is Matinas Biopharma's official website?

    Matinas Biopharma's official website is https://www.matinasbiopharma.com

  • What is Matinas Biopharma's Revenue?

    Matinas Biopharma's revenue is $10 - 50M

  • What is Matinas Biopharma's NAICS code?

    Matinas Biopharma's NAICS code is 541715

  • How many employees are working in Matinas Biopharma

    Matinas Biopharma has 25 employees

  • What is Matinas Biopharma's Industry?

    Matinas Biopharma is in the industry of Biotechnology

  • Who is Matinas Biopharma's CEO?

    Matinas Biopharma's CEO is Jerry Jabbour

Company Directory